Association of Interleukin-4 and Interleukin-1 Receptor Antagonist Gene Polymorphisms and Risk of Benign Prostatic Hyperplasia

Urology

Volumn 71, Issue 5, 2008, Pages 868-872

  Konwar, Rituraj ^a   Gara, Rishi ^a   Singh, Manmohan ^a   Singh, Vishwajeet ^b   Chattopadhyay, Naibedya ^a   Bid, Hemant Kumar ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

^b KING GEORGE'S MEDICAL UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 4; STEROID 5ALPHA REDUCTASE INHIBITOR;

ADULT; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHARMACOGENETICS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; RECEPTOR GENE; STATISTICAL DISTRIBUTION; STATISTICAL SIGNIFICANCE; TREATMENT RESPONSE; VARIABLE NUMBER OF TANDEM REPEAT;

CASE-CONTROL STUDIES; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-4; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROSTATIC HYPERPLASIA; RISK FACTORS;

EID: 42949103563     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2007.12.072     Document Type: Article

References (23)

1. Kramer G., Mitteregger D., and Marberger M. Is benign prostatic hyperplasia (BPH) an immune inflammatory disease?. Eur Urol 51 (2007) 1202-1216
2. Chomarat P., Vannier E., Dechanet J., et al. Balance of IL-1 receptor antagonist/IL-1 beta in rheumatoid synovium and its regulation by IL-4 and IL-10. J Immunol 154 (1995) 1432-1439
3. Kramer G., Steiner G.E., Handisurya A., et al. Increased expression of lymphocyte-derived cytokines in benign hyperplastic prostate tissue, identification of the producing cell types, and effect of differentially expressed cytokines on stromal cell proliferation. Prostate 52 (2002) 43-58
4. Arai N., Nomura D., Villaret D., et al. Complete nucleotide sequence of the chromosomal gene for human IL-4 and its expression. J Immunol 142 (1989) 274-282
5. Kate E., Elizabeth F., David H., et al. The -590C/T and -34C/T interleukin-4 promoter polymorphisms are not associated with atopic eczema in childhood. J Allerg Clin Immunol 108 (2001) 285-287
6. Mout R., Willemze R., and Landegent J.E. Repeat polymorphisms in the interleukin-4 gene. Nucleic Acids Res 19 (1991) 3763
7. Nakashima H., Miyake K., Inoue Y., et al. Association between IL-4 genotype and IL-4 production in the Japanese population. Genes Immun 2 (2002) 107-109
8. Arend W.P., Malyak M., Guthridge C.J., et al. Interleukin-1 receptor antagonist: role in biology. Annu Rev Immunol 16 (1998) 27-55
9. Dinarello C.A. The interleukin-1 family: 10 years of discovery. FASEB J 8 (1994) 1314-1325
10. Giri D., and Ittmann M. Interleukin-1α is a paracrine inducer of FGF7, a key epithelial growth factor in benign prostatic hyperplasia. Am J Pathol 157 (2000) 249-255
11. Patricia C., Giri D., Dolores L., et al. Cellular senescence in the pathogenesis of benign prostatic hyperplasia. Prostate 55 (2003) 30-38
12. Ricote M., García-Tuñón I., Bethencourt F.R., et al. Interleukin-1 (IL-1α and IL-1β) and its receptors (IL-1RI, IL-1RII, and IL-1Ra) in prostate carcinoma. Cancer 7 (2004) 1388-1396
13. Steinkasserer A., Spurr N.K., Cox S., et al. The human IL-1 receptor antagonist gene (IL1RN) maps to chromosome 2q14-q21, in the region of IL-1 alpha and IL-beta loci. Genomics 13 (1992) 654-657
14. Tarlow J.K., Blakemore A.I.F., Lennard A., et al. Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of and 86 base pair tandem repeat. Hum Genet 91 (1993) 403-404
15. Vamvakopoulos J.E., Taylor C.J., Morris-Stiff G.J., et al. The interleukin-1 receptor antagonist gene: a single-copy variant of the intron 2 variable number tandem repeat (VNTR) polymorphism. Eur J Immunogenet 29 (2002) 337-340
16. Hurme M., and Santtila S. IL-1 receptor antagonist (IL-1Ra) plasma levels are co-ordinately regulated by both IL-1Ra and IL-1beta genes. Eur J Immunol 28 (1998) 2598-2602
17. Cullup H., Middleton P.G., Duggan G., et al. Environmental factors and not genotype influence the plasma level of interleukin-1 receptor antagonist in normal individuals. Clin Exp Immunol 137 (2004) 351-358
18. Mittal R.D., Mishra D.K., Bid H.K., et al. Interleukin-1 receptor antagonist polymorphism in patients with prostate cancer and benign prostatic hyperplasia: a case control study from North India. Urol Oncol 4 (2004) 131-134
19. Bioque G., Crusius J.B.A., Koutroubakis I., et al. Allelic polymorphism in IL-1β and IL-1 receptor antagonist (IL-Ra) genes in inflammatory bowl disease. Clin Exp Immunol 102 (1995) 379-383
20. Gauderman W.J. Sample size requirements for association studies of gene-gene interaction. Am J Epidemiol 155 (2002) 478-484
21. Nakamura E., Takahashi S., and Ishikawa M. Inhibitory effect of macrophage-derived factors on the recovery of wounds induced in rat gastric epithelial monolayers. Biochem Pharmacol 58 (1999) 1221-1227
22. Sanda M.G., Beaty T.H., Stutzman R.E., et al. Genetic susceptibility of benign prostatic hyperplasia. J Urol 152 (1994) 115-119
23. Partin A.W., Page W.F., Lee B.R., et al. Concordance rates for benign prostatic disease among twins suggest hereditary influence. Urology 44 (1994) 646-650